{"nct_id":"NCT04417530","title":"Phase 2 Trial to Evaluate Belzupacap Sarotalocan (AU-011) Via Suprachoroidal Administration in Subjects With Primary Indeterminate Lesions and Small Choroidal Melanoma","status":"COMPLETED","status_verified_date":"2025-02","start_date":"2020-08-05","start_date_type":"ACTUAL","primary_completion_date":"2024-04-22","primary_completion_date_type":"ACTUAL","completion_date":"2024-04-22","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["AURA"]}